Explore a little further

Nvidia

Stories and perspectives from Daytrade News.

From Daytrade News

12 stories shown · Newest added
Daytrade News

Nvidia Invests in Generate Biomedicines to Enhance AI Drug Discovery

Nvidia's venture arm, NVentures, has acquired 833,325 shares in Generate Biomedicines, valued at approximately $10.4 million. Generate is developing an AI-driven platform for drug discovery, currently conducting a Phase 3 clinical trial for severe asthma and has several oncology…

Daytrade News

Cerebras Shares Drop Despite Strong Earnings Report

Cerebras Systems reported its first earnings as a public company, exceeding revenue expectations with Q1 2026 revenue of $193.4 million, a 94% increase year-over-year. However, sh…

More perspectives

Across our publications

A selection of related stories